Vascularized Bone Autograft for the Treatment of Chondroblastoma of the Talus at Imminent Risk of Joint Breakdown: Three Case Reports.


Journal

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
ISSN: 1542-2224
Titre abrégé: J Foot Ankle Surg
Pays: United States
ID NLM: 9308427

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 28 11 2017
pubmed: 8 1 2019
medline: 31 7 2019
entrez: 8 1 2019
Statut: ppublish

Résumé

Surgical treatment options in a chondroblastoma of the talus breaching the subchondral layer with imminent risk of talar collapse in the weightbearing area are limited. A joint-preserving surgery should be advocated. Because current treatment options such as curettage, cryosurgery, or radiofrequency ablation may not be able to prevent a talar dome breakdown in large defects, nonvascularized bone grafting has been advocated to fill the void. To overcome the lack of vitality, a vascularized bone autograft might be an attractive alternative. We present 3 cases where a large talar defect owing to a chondroblastoma was treated with a vascularized bone autograft. In 1 of the cases, a free microvascular iliac crest bone graft was used, whereas in the other 2 cases, a vascularized graft was harvested from the medial femoral condyle. Computed tomographic scans demonstrated a stable incorporation of the graft in all cases. All patients were highly satisfied with the obtained results and showed a clinical functional outcome similar to the contralateral foot after 36, 60, and 72 months. At the latest radiographic follow-up, no evidence of recurrence was observed. In conclusion, a free vascularized bone autograft can be used to treat a large talar defect owing to chondroblastoma in young patients.

Identifiants

pubmed: 30612869
pii: S1067-2516(18)30394-6
doi: 10.1053/j.jfas.2018.08.053
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

363-367

Informations de copyright

Copyright © 2018 the American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Joe Wagener (J)

Attending Surgeon, Clinic of Orthopaedic Surgery, Kantonsspital Baselland, Liestal, Switzerland. Electronic address: joewagener@gmail.com.

Christine Schweizer (C)

Research Associate, Clinic of Orthopaedic Surgery, Kantonsspital Baselland, Liestal, Switzerland.

Tamara Horn Lang (T)

Research Associate, Clinic of Orthopaedic Surgery, Kantonsspital Baselland, Liestal, Switzerland.

Lukas Zwicky (L)

Research Associate, Clinic of Orthopaedic Surgery, Kantonsspital Baselland, Liestal, Switzerland.

Dirk Johannes Schaefer (DJ)

Professor, Plastic Surgeon, University Hospital, Basel, Switzerland.

Beat Hintermann (B)

Professor, Associate Professor, and Chair, Clinic of Orthopaedic Surgery, Kantonsspital Baselland, Liestal, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH